Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
May 02, 2024
May 02, 2024
SANTA CLARA, California, May 2 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains--from basic research to drug dis . . .
Agilent Technologies Inc. (NYSE: A) has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system sets a gold standard for acquiring, analyzing, and reporting flow data across diverse domains--from basic research to drug dis . . .